S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LEXXW Lexaria Bioscience Corporation

0.79

0.0429 (5.74%)

Last Updated: 11:07:28

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corporation News

Form 8-K - Current report
Wednesday 18 December 2024 (5 days ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 17 December 2024 (6 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 16 December 2024 (7 days ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 5 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 18 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 16 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 2 October 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Monday 23 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 September 2024 (4 months ago) • Edgar (US Regulatory)

More Lexaria Bioscience Corporation News Articles

INTESA SANPAOLO

Strategic Minerals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions